| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 05/11/2011 | CN102050758A Novel amide derivatives and medicinal use thereof |
| 05/11/2011 | CN101367761B 6,7- substituted-2,2,4-trimethyl-tetrahydroquinoline-1-carboxylic acid aryl amide, synthesis and uses thereof |
| 05/11/2011 | CN101353323B Purification method of 2-methyl quinoline |
| 05/10/2011 | US7939667 Hepatitis C inhibitor compounds |
| 05/10/2011 | US7939661 Pyridine, quinoline and pyrimidine derivatives |
| 05/10/2011 | US7939545 Inhibitors of human immunodeficiency virus replication |
| 05/10/2011 | US7939526 Sulfone substituted imidazo ring ethers |
| 05/10/2011 | US7939185 Fused polycyclic compounds and organic light-emitting device using the same |
| 05/10/2011 | CA2433158C Pyridone derivatives having a binding activity to the cannabinoid type 2 receptor |
| 05/10/2011 | CA1341613C Assays utilizing improved chemiluminescent esters, thioesters and amides |
| 05/05/2011 | WO2011009540A3 Pesticidal carboxamides |
| 05/05/2011 | WO2005060456A9 Method for treating adamts-5-associate disease |
| 05/05/2011 | US20110105757 Method for preparation of montelukast acid in ionic liquid medium |
| 05/05/2011 | US20110105756 Process for Preparing Quinoline-3-Carboxamide Derivatives |
| 05/05/2011 | US20110105747 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
| 05/05/2011 | US20110105513 AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 05/05/2011 | US20110105485 Alpha-(N-Sulfonamido)Acetamide Derivatives as Beta-Amyloid Inhibitors |
| 05/05/2011 | US20110105329 Substituted Quinolinones Having Herbicidal Action |
| 05/05/2011 | US20110104315 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 05/05/2011 | US20110104162 Compounds which can be used for the Treatment of Cancers |
| 05/04/2011 | CN102046603A [4-(1-amino-ethyl)-cyclohexyl]-methyl-amine and [6-(1-amino-ethyl) -tetrahydro-pyran-3-yl]-methyl-amine derivatives as antibacterials |
| 05/04/2011 | CN102046602A Process for making montelukast intermediates |
| 05/04/2011 | CN102040591A 7-phenyl quinolone compounds |
| 05/04/2011 | CN102040193A Method for preparing organic micromolecule nano ring and nano tube |
| 05/04/2011 | CN101585808B Method for asymmetric catalytic hydrogenation of quinoline derivatives |
| 05/04/2011 | CN101531633B Purification method of quinaldine |
| 05/03/2011 | US7935827 Optically active, heteroaromatic β-hydroxy esters and processes for their preparation from β-keto esters and processes for the preparation of these β-keto esters |
| 05/03/2011 | US7935713 Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use |
| 05/03/2011 | US7935510 Modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms |
| 05/03/2011 | CA2484340C 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 05/03/2011 | CA2439709C Aryl and heteroaryl urea chki inhibitors for use as radiosensitizers and chemosensitizers |
| 04/28/2011 | WO2011050215A1 Process for preparing modulators of cystic fibrosis transmembrane conductance regulator |
| 04/28/2011 | WO2011047643A1 Method for the preparation of (ls)-6,7-dimethoxy-l-[2-(4-trifluoromethylphenyl)ethyl]- 1,2,3,4-tetrahydroisoquinoline |
| 04/28/2011 | WO2011047432A1 Fused ring analogues of anti-fibrotic agents |
| 04/28/2011 | WO2011004389A3 An improved process for the preparation of elvitegravir |
| 04/28/2011 | US20110098504 Histone Deacetylase Inhibitors and Methods of Use Thereof |
| 04/28/2011 | US20110098431 Catalyst Compounds and Use Thereof |
| 04/28/2011 | US20110098285 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 04/28/2011 | US20110097409 Particles comprising a salt of 8-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone having improved adhesion properties for powder formulations for inhalation |
| 04/28/2011 | US20110095282 Organic electroluminescent device comprising triazine derivatives |
| 04/28/2011 | CA2778492A1 Process for preparing modulators of cystic fibrosis transmembrane conductance regulator |
| 04/27/2011 | EP2314590A1 Substituted quinolones and methods of use |
| 04/27/2011 | EP2314568A2 Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives |
| 04/27/2011 | EP2313373A1 Heterocyclic derivatives that are used in the treatment of neurodegenerative diseases |
| 04/27/2011 | EP2312949A1 N-heterocyclic m1 receptor positive allosteric modulators |
| 04/27/2011 | EP2312948A1 5-quinolinone and imidazopyridine compounds and use thereof |
| 04/27/2011 | CN102036963A Derivatives of quinolines and quinoxalines as protein tyrosine kinase inhibitors |
| 04/27/2011 | CN102036962A Combined use of angiogenesis inhibitor and taxane |
| 04/27/2011 | CN102030706A Method for preparing 6-hydroxy-2(1H)-quinolone in ionic liquid by using one-pot method |
| 04/27/2011 | CN102030705A Synthesis method of 7- benzyloxy-6-methoxyl-4-hydroxyquinoline |
| 04/26/2011 | US7932392 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 04/26/2011 | CA2477657C Cathepsin cysteine protease inhibitors |
| 04/21/2011 | WO2011046991A2 Certain substituted ureas as modulators of kinase activity |
| 04/21/2011 | WO2011046082A1 Oxime ether derivative or salt thereof, and agricultural/horticultural germicide |
| 04/21/2011 | WO2011045084A1 Quinolinyloxyphenylsulfonamides |
| 04/21/2011 | WO2011044637A1 Affinity ligands and methods for protein purification |
| 04/21/2011 | US20110092708 Process for the preparation of montelukast and its salts thereof |
| 04/21/2011 | US20110092701 Compounds for electronic devices |
| 04/21/2011 | US20110092504 Inhibitors of pi3 kinase |
| 04/21/2011 | US20110092503 Quinoline derivatives as axl kinase inhibitors |
| 04/21/2011 | US20110092488 Quninoline Methanol Compounds for the Treatment and Prevention of Parasitic Infections |
| 04/21/2011 | US20110092476 Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
| 04/21/2011 | US20110092368 2,4,6-Phenyl-substituted cyclic ketoenols |
| 04/20/2011 | EP2311809A1 Quinolinyloxyphenylsulfonamides |
| 04/20/2011 | EP2310356A1 Adamantyl diamide derivatives and uses of same |
| 04/20/2011 | EP2309860A1 Monocyclic cyanoenones and methods of use thereof |
| 04/20/2011 | EP1928835B1 Alkyl sulfoxide quinolines as nk-3 receptor ligands |
| 04/20/2011 | EP1375485B1 Method for preparing 7-quinolinyl-3,5-dihydroxyhept-6-enoate |
| 04/20/2011 | CN102026961A Amide compound |
| 04/20/2011 | CN102020608A Preparation method of 4-benzylquinoline compound |
| 04/20/2011 | CN101538252B Novel preparation method and intermediate for aripiprazole |
| 04/19/2011 | US7928239 Anticarcinogenic agents |
| 04/19/2011 | US7928137 Meta-benzamidine derivatives as serine protease inhibitors |
| 04/19/2011 | US7928122 Modulators of cellular adhesion |
| 04/19/2011 | CA2476012C Substituted pyridinones as modulators of p38 map kinase |
| 04/14/2011 | WO2011042416A1 Sythesis of optically active intermediate for the preparation of montelukast |
| 04/13/2011 | EP2308873A1 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents |
| 04/13/2011 | EP2308848A1 Quinoline-derived amide modulators of vanilloid VR1 receptor |
| 04/13/2011 | EP2308846A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308845A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308844A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308828A2 CaSR antagonist |
| 04/13/2011 | EP2307401A2 Antineoplastic derivatives of 4-oxo-1,4-dihydro-quinoline, preparation thereof, and therapeutic use thereof |
| 04/13/2011 | CN1958568B A kind of compound for preventing or curing infection of helicobacter pylori, preparation method, and application |
| 04/13/2011 | CN1882547B 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 04/13/2011 | CN102017218A Organic electroluminescent element |
| 04/13/2011 | CN102015650A 2-aminoquinoline derivatives as 5-HT(5A) receptor antagonists |
| 04/13/2011 | CN102015606A IRE-1a inhibitors |
| 04/13/2011 | CN102015585A Method for producing unsaturated organic compound |
| 04/13/2011 | CN102010373A Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof |
| 04/13/2011 | CN102010370A Analytical reagent for heavy metal measurement as well as preparation method and application thereof |
| 04/13/2011 | CN102010369A Method for continuously preparing 2,2,4-trimethyl-1,2-dihydride quinoline |
| 04/13/2011 | CN102010368A Production process of antioxidant RD |
| 04/13/2011 | CN102008459A Antibacterial agents |
| 04/13/2011 | CN101421230B Novel phenyl-propargylether derivatives |
| 04/13/2011 | CN101321732B Process for the preparation of a leukotriene antagonist and intermediates thereof |
| 04/13/2011 | CN101239945B Aminoquinoline derivatives and their use as adenosine a3 ligands |
| 04/12/2011 | US7923562 Photocleavable linker methods and compositions |
| 04/12/2011 | US7923561 Quinolines |
| 04/12/2011 | US7923461 TNF-α production inhibitors |